[DPHARMA] QoQ Cumulative Quarter Result on 30-Sep-2022 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
09-Nov-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
30-Sep-2022 [#3]
Profit Trend
QoQ- 44.67%
YoY- 5.97%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 367,991 200,475 696,717 544,757 367,683 185,941 639,175 -30.86%
PBT 44,805 28,292 84,851 69,504 48,119 26,646 82,983 -33.76%
Tax -9,633 -5,659 -14,739 -16,553 -11,517 -6,355 -17,300 -32.38%
NP 35,172 22,633 70,112 52,951 36,602 20,291 65,683 -34.13%
-
NP to SH 35,172 22,633 70,112 52,951 36,602 20,291 65,683 -34.13%
-
Tax Rate 21.50% 20.00% 17.37% 23.82% 23.93% 23.85% 20.85% -
Total Cost 332,819 177,842 626,605 491,806 331,081 165,650 573,492 -30.49%
-
Net Worth 670,448 666,567 657,045 647,522 634,375 621,987 621,564 5.19%
Dividend
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Div 4,788 - 21,901 4,761 4,734 - 21,660 -63.54%
Div Payout % 13.62% - 31.24% 8.99% 12.93% - 32.98% -
Equity
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Net Worth 670,448 666,567 657,045 647,522 634,375 621,987 621,564 5.19%
NOSH 961,942 952,239 952,239 952,239 952,239 941,765 941,765 1.42%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 9.56% 11.29% 10.06% 9.72% 9.95% 10.91% 10.28% -
ROE 5.25% 3.40% 10.67% 8.18% 5.77% 3.26% 10.57% -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
RPS 38.42 21.05 73.17 57.21 38.83 20.03 67.87 -31.64%
EPS 3.68 2.38 7.39 5.59 3.88 2.19 6.98 -34.81%
DPS 0.50 0.00 2.30 0.50 0.50 0.00 2.30 -63.94%
NAPS 0.70 0.70 0.69 0.68 0.67 0.67 0.66 4.01%
Adjusted Per Share Value based on latest NOSH - 952,239
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
RPS 38.23 20.83 72.37 56.59 38.19 19.32 66.40 -30.86%
EPS 3.65 2.35 7.28 5.50 3.80 2.11 6.82 -34.15%
DPS 0.50 0.00 2.28 0.49 0.49 0.00 2.25 -63.41%
NAPS 0.6965 0.6924 0.6825 0.6726 0.659 0.6461 0.6457 5.19%
Price Multiplier on Financial Quarter End Date
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Date 30/06/23 31/03/23 30/12/22 30/09/22 30/06/22 31/03/22 31/12/21 -
Price 1.30 1.56 1.61 1.30 1.20 1.49 1.68 -
P/RPS 3.38 7.41 2.20 2.27 3.09 7.44 2.48 22.99%
P/EPS 35.40 65.63 21.87 23.38 31.04 68.17 24.09 29.34%
EY 2.82 1.52 4.57 4.28 3.22 1.47 4.15 -22.76%
DY 0.38 0.00 1.43 0.38 0.42 0.00 1.37 -57.56%
P/NAPS 1.86 2.23 2.33 1.91 1.79 2.22 2.55 -19.01%
Price Multiplier on Announcement Date
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Date 24/08/23 22/05/23 23/02/23 09/11/22 16/08/22 17/05/22 15/02/22 -
Price 1.19 1.44 1.65 1.39 1.34 1.51 1.60 -
P/RPS 3.10 6.84 2.26 2.43 3.45 7.54 2.36 20.00%
P/EPS 32.41 60.59 22.41 25.00 34.66 69.08 22.94 25.98%
EY 3.09 1.65 4.46 4.00 2.88 1.45 4.36 -20.55%
DY 0.42 0.00 1.39 0.36 0.37 0.00 1.44 -56.11%
P/NAPS 1.70 2.06 2.39 2.04 2.00 2.25 2.42 -21.02%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment